84 related articles for article (PubMed ID: 38390620)
1. Elevated hyaluronic acid levels in severe SARS-CoV-2 infection in the post-COVID-19 era.
Li Y; Cui X; Zhu N; Lin Y; Li X
Front Cell Infect Microbiol; 2024; 14():1338508. PubMed ID: 38390620
[TBL] [Abstract][Full Text] [Related]
2. Safety of lung resection surgery after severe acute respiratory syndrome coronavirus 2 infection in the post-vaccination era.
Im S; Na KJ; Park JH; Na B; Park S; Park IK; Kang CH; Kim YT
Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38532301
[TBL] [Abstract][Full Text] [Related]
3. Serum surfactant protein D in COVID-19 is elevated and correlated with disease severity.
Tong M; Xiong Y; Zhu C; Xu H; Zheng Q; Jiang Y; Zou L; Xiao X; Chen F; Yan X; Hu C; Zhu Y
BMC Infect Dis; 2021 Aug; 21(1):737. PubMed ID: 34344306
[TBL] [Abstract][Full Text] [Related]
4. Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study.
Chiu LC; Lee CS; Hsu PC; Li HH; Chan TM; Hsiao CC; Kuo SC; Ko HW; Lin SM; Wang CH; Lin HC; Chu PH; Yen TH
Environ Health; 2024 Mar; 23(1):29. PubMed ID: 38504259
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl-peptidase 3 and IL-6: potential biomarkers for diagnostics in COVID-19 and association with pulmonary infiltrates.
Staudner ST; Leininger SB; Vogel MJ; Mustroph J; Hubauer U; Meindl C; Wallner S; Lehn P; Burkhardt R; Hanses F; Zimmermann M; Scharf G; Hamer OW; Maier LS; Hupf J; Jungbauer CG
Clin Exp Med; 2023 Dec; 23(8):4919-4935. PubMed ID: 37733154
[TBL] [Abstract][Full Text] [Related]
6. How long can pulmonary resection surgery be performed after SARS-CoV-2 infection? A multicenter retrospective study.
Duan J; Zhou Y; Hui B; Zhao Y; Shang R; Qiao B; Zhou Y; Yang W; Cui K; Zhang X; Yan X; Jiang T; Lei J
Int J Surg; 2024 Mar; 110(3):1605-1610. PubMed ID: 38116668
[TBL] [Abstract][Full Text] [Related]
7. Significance of Hypoalbuminemia in the Development of Thromboembolic Complications in Severe Cases of SARS-CoV-2 Coronavirus Infection.
Tarzimanova A; Bragina A; Pokrovskaya A; Ivannikov A; Sokolova E; Cherkesov I; Safronova T; Vargina T; Ponomareva L; Isaeva A; Oganesyan K; Podzolkov V
J Clin Med Res; 2024 Apr; 16(4):164-169. PubMed ID: 38715557
[TBL] [Abstract][Full Text] [Related]
8. Serum VEGF-A levels on admission in COVID-19 patients correlate with SP-D and neutrophils, reflecting disease severity: A prospective study.
Tsuji M; Kondo M; Sato Y; Miyoshi A; Kobayashi F; Arimura K; Yamashita K; Morimoto S; Yanagisawa N; Ichihara A; Tagaya E
Cytokine; 2024 Jun; 178():156583. PubMed ID: 38554499
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19.
Matsuyama T; Yoshinaga SK; Shibue K; Mak TW
Cell Death Differ; 2021 Dec; 28(12):3199-3213. PubMed ID: 34663907
[TBL] [Abstract][Full Text] [Related]
10. Sysmex-derived COVID-19 prognostic score as an early prognostic marker for severity of the COVID-19 disease.
Blažek M; Vrbacký F; Fátorová I; Mirská K; Žák P
Int J Lab Hematol; 2024 Apr; 46(2):243-249. PubMed ID: 37921205
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Potential of the Plasma Lipidome in Infectious Disease: Application to Acute SARS-CoV-2 Infection.
Gray N; Lawler NG; Zeng AX; Ryan M; Bong SH; Boughton BA; Bizkarguenaga M; Bruzzone C; Embade N; Wist J; Holmes E; Millet O; Nicholson JK; Whiley L
Metabolites; 2021 Jul; 11(7):. PubMed ID: 34357361
[TBL] [Abstract][Full Text] [Related]
12. Association between COVID-19 severity and relatively high serum adiponectin levels at the time of admission.
Mineo R; Fukuda S; Suzuki S; Ito Y; Tamba S; Sugiyama T; Fujishima Y; Nishizawa H; Shimomura I; Yamamoto K; Matsuzawa Y
Endocr J; 2024 May; ():. PubMed ID: 38735737
[TBL] [Abstract][Full Text] [Related]
13. Identification of predictive patient characteristics for assessing the probability of COVID-19 in-hospital mortality.
Rajwa B; Naved MMA; Adibuzzaman M; Grama AY; Khan BA; Dundar MM; Rochet JC
PLOS Digit Health; 2024 Apr; 3(4):e0000327. PubMed ID: 38652722
[TBL] [Abstract][Full Text] [Related]
14. Understanding COVID-19 outcome: Exploring the prognostic value of soluble biomarkers indicative of endothelial impairment.
Mariappan V; Adla D; Jangili S; Ranganadin P; Green SR; Mohammed S; Mutheneni SR; Pillai AB
Cytokine; 2024 Jun; 180():156673. PubMed ID: 38857562
[TBL] [Abstract][Full Text] [Related]
15. [Staging of COVID-19 morphological manifestations in lungs depending on disease duration].
Fedulova MV
Sud Med Ekspert; 2024; 67(2):28-31. PubMed ID: 38587155
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Fingerprint of the SARS-CoV-2 Infection in the Lung of Lethal COVID-19.
Noguera-Castells A; Parra J; Davalos V; García-Prieto CA; Veselinova Y; Pérez-Miés B; Caniego-Casas T; Palacios J; Saenz-Sardà X; Englund E; Musulen E; Esteller M
Chest; 2024 Apr; 165(4):820-824. PubMed ID: 37914026
[No Abstract] [Full Text] [Related]
17. Peripheral biomarkers as a predictor of poor prognosis in severe cases of COVID-19.
da Silva GB; Manica D; da Silva AP; Valcarenghi E; Donassolo SR; Kosvoski GC; Mingoti MED; Gavioli J; Cassol JV; Hanauer MC; Hellmann MB; Marafon F; Bertollo AG; de Medeiros J; Cortez AD; Réus GZ; de Oliveira GG; Ignácio ZM; Bagatini MD
Am J Med Sci; 2024 Apr; ():. PubMed ID: 38636654
[TBL] [Abstract][Full Text] [Related]
18. Neurological and Psychiatric Disorders in the COVID-19 Era.
Ercoli T; Loy F; Masala C; Solla P
Brain Sci; 2024 Apr; 14(4):. PubMed ID: 38672007
[TBL] [Abstract][Full Text] [Related]
19. Fungal infections in the era of COVID-19: Time to awaken to the Titanic.
Singla N; Bansal Y
Indian J Pathol Microbiol; 2024 Apr; 67(2):481-482. PubMed ID: 38391325
[No Abstract] [Full Text] [Related]
20. Family medicine in the era of endemic COVID-19.
Pimlott N
Can Fam Physician; 2021 Nov; 67(11):799. PubMed ID: 34772702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
